Ret function in muscle stem cells points to tyrosine kinase inhibitor therapy for facioscapulohumeral muscular dystrophy. (2016)
Attributed to:
Strategic Partnership in Skeletal Muscle Biology
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.7554/elife.11405
PubMed Identifier: 27841748
Publication URI: http://europepmc.org/abstract/MED/27841748
Type: Journal Article/Review
Volume: 5
Parent Publication: eLife
ISSN: 2050-084X